NYXOAH news, videos and press releases - Page 2
For more news please use our advanced search feature.
NYXOAH - More news...
NYXOAH - More news...
- Nyxoah Announces Proposed Offering of Ordinary Shares
- Nyxoah Reports First Quarter 2024 Financial and Operating Results
- Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024
- Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
- Information on the total number of voting rights and shares
- Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
- Nyxoah Announces 2024 Strategic Priorities
- Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®
- Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference
- Nyxoah Reports Third Quarter 2023 Financial and Operating Results
- Nyxoah Announces Partnership with ResMed in Germany
- Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results
- Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference
- Nyxoah Reports First Quarter 2023 Financial and Operating Results
- Invitation to Attend the Annual Shareholders’ Meeting of the Company to be Held on June 14, 2023
- Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer
- Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023
- Information on the Total Number of Voting Rights and Shares
- Nyxoah Announces a $15 Million Private Placement Financing
- Nyxoah Announces Inaugural Investor & Analyst Meeting
- Nyxoah Announces Inaugural Investor & Analyst Meeting
- Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors
- Nyxoah to Participate in the Piper Sandler 34th Annual Healthcare Conference
- Nyxoah Announces Change to Board of Directors
- Nyxoah to Participate in the Jefferies London Healthcare Conference
- Nyxoah to Release Third Quarter Financial Results on November 8, 2022
- Nyxoah to Participate in the 17th Annual Wells Fargo Securities Healthcare Conference
- Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022
- Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio® in Complete Concentric Collapse Patients
- Information on the total number of voting rights and shares
